stocktools
Offerings // BriaCell Therapeutics Corp.

BCTX offering history

Every offering-related filing in BriaCell Therapeutics Corp.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 324 filings back to Jun 20, 2014.

Last executed offering
Jun 3, 2026
8-K — priced deal (shares or notes)
Last registration (announced)
Jan 13, 2026
S-1MEF — capacity, not a sale
Executed, last 12 months
3
424B pricings + 8-K 3.02 sales
Registered, last 12 months
2
S-1/S-3/F-series registrations
DateFilingWhat it means
Jun 3, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jun 2, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 14, 2026424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Jan 13, 2026S-1MEF →REGISTEREDS-1MEF registration — capacity to sell shares, not a sale yet
Jan 13, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 23, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Dec 23, 2025FWP →MARKETINGFree-writing prospectus — offering being marketed
Jul 16, 2025424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Jul 15, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 11, 2025FWP →MARKETINGFree-writing prospectus — offering being marketed
Jul 10, 2025S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jul 9, 2025S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jul 8, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Jul 8, 2025FWP →MARKETINGFree-writing prospectus — offering being marketed
Apr 28, 2025424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Apr 28, 2025424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Apr 24, 2025S-1MEF →REGISTEREDS-1MEF registration — capacity to sell shares, not a sale yet
Apr 24, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 23, 2025S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Apr 22, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Apr 22, 2025FWP →MARKETINGFree-writing prospectus — offering being marketed
Feb 5, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Feb 4, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 3, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 13, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Dec 12, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 11, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 2, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 12, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 12, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
May 16, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 31, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jan 22, 2024S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
May 22, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Mar 28, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 21, 2022424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 16, 2022EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Nov 26, 2021424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Nov 23, 2021EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Oct 18, 2021424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
BCTX offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full BCTX workspace →
BCTX offering FAQ

When did BCTX last execute an offering?

Per SEC filings, BriaCell Therapeutics Corp.'s most recent priced offering document is a 8-K filed 2026-06-03. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did BCTX last announce or register an offering?

The most recent registration is a S-1MEF filed 2026-01-13. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.